Mark Connelly,
Chief Industrial Operations and R&D Officer, U.S.,
Menarini Silicon Biosystems, Inc.
Mark C. Connelly, Ph.D., is Chief Industrial Operations and Research & Development Officer, US for Menarini Silicon Biosystems. He has been leading research and development in the field of rare cell detection and analysis for over 15 years. Dr. Connelly previously served as Vice President of Reagent Development for Immunicon Corporation; Veridex, LLC; and Scientific Director for Janssen Diagnostics. Over the last 30 years, Dr. Connelly has lead the development and commercialization of numerous IVD and RUO products and services in the fields of Clinical Chemistry, Retrovirology, Flow Cytometry, Blood Banking, Autoimmunity, Cancer Diagnostics, and Pharmaceutical Drug Development. Dr. Connelly received his B.S. in Biology from Syracuse University, and his Ph.D. in Immunochemistry from the University of Rochester.
Rare Cell Characterization
Wednesday, 30 September 2015 at 09:30
Add to Calendar ▼2015-09-30 09:30:002015-09-30 10:30:00Europe/LondonRare Cell CharacterizationNGS, SCA, Mass Spec: The Road to Diagnostics in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Tumors spreading via a patient’s vasculature, is a well-established and simple concept. The biology that drives it however, is complex and dynamic. In order to shift cancer treatment regimens from tumor-reactive to tumor-proactive we must develop increasingly sophisticated tools for analyzing circulating tumor materials, properly dissecting the underlying biological complexity, and intercepting the disease earlier in the transformation process. We will present the use of an emerging microfluidic technology whose negative depletion technology demonstrates the ability to enrich and purify essentially all populations of circulating tumor cells, tumor related cells, as well as harvest plasma for cfDNA and other markers. Molecular and phenotypic analysis on enriched products will illustrate the ability of the platform to be used for research on non-epithelial tumors and to investigate early disease interception.
Add to Calendar ▼2015-09-28 00:00:002015-09-30 00:00:00Europe/LondonNGS, SCA, Mass Spec: The Road to DiagnosticsNGS, SCA, Mass Spec: The Road to Diagnostics in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2015-09-30 09:30:002015-09-30 10:30:00Europe/LondonRare Cell CharacterizationNGS, SCA, Mass Spec: The Road to Diagnostics in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
